Ionis Pharmaceuticals
IONS
44.16
+0.16
+0.36%
Ionis Pharmaceuticals
US · IONS
#1749 by market cap
Listed 1970
44.16
+0.16
+0.36%
Live - 5344 symbols - heartbeat 222s ago
· 2026-10-08 07:13
Pre-market
44.41
+0.57%
After-hours
44.16
0.00%
- Market cap
- 7.34B
- P/E (TTM)i
- -12.69
- P/Bi
- 16.69
- EPSi
- -2.38
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on IONS?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 21 analysts
Buy
Avg price target
84.00 +90.2%
Price target rangecurrent 44.16
Low54.00
Avg84.00
High104.00
Buy 81%
Hold 19%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-24 | CCORF | -- | BUY | 85.00 |
| 2026-09-24 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-09-24 | Oppenheimer | -- | BUY | 85.00 |
| 2026-09-23 | TD Cowen | -- | BUY | 84.00 |
| 2026-09-23 | CCORF | -- | BUY | 85.00 |
| 2026-09-23 | Needham | -- | BUY | 86.00 |
| 2026-09-23 | BMO Capital | -- | HOLD | 54.00 |
| 2026-09-23 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-09-22 | William Blair | -- | BUY | -- |
| 2026-09-22 | J.P. Morgan | -- | BUY | 70.00 |
| 2026-09-18 | Barclays | -- | BUY | 85.00 |
| 2026-09-14 | Goldman Sachs | -- | HOLD | 56.00 |
| 2026-09-14 | Guggenheim | -- | BUY | 80.00 |
| 2026-09-09 | Morgan Stanley | -- | BUY | 104.00 |
| 2026-09-08 | TD Cowen | -- | BUY | 84.00 |
| 2026-09-08 | CCORF | -- | BUY | 85.00 |
| 2026-09-08 | Raymond James | -- | BUY | 84.00 |
| 2026-09-08 | BofA Securities | -- | BUY | 91.00 |
| 2026-09-08 | Morgan Stanley | -- | BUY | 104.00 |
| 2026-09-08 | Needham | -- | BUY | 86.00 |
| 2026-09-08 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-09-08 | Barclays | -- | BUY | 85.00 |
| 2026-09-04 | TD Cowen | -- | BUY | 94.00 |
| 2026-09-04 | CCORF | -- | BUY | 95.00 |
| 2026-09-04 | William Blair | -- | BUY | -- |
Quant vs Street three independent views, side by side
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-29 | -- | ±8.18% | -2.28% (in line) |
| 2026/Q1 | 2026-04-29 | -- | ±5.49% | +4.25% (in line) |
| 2025/Q4 | 2026-02-25 | -- | ±9.19% | -5.29% (in line) |
| 2025/Q3 | 2025-10-29 | -- | ±10.87% | -2.30% (in line) |
| 2025/Q2 | 2025-07-30 | -- | ±10.68% | +4.56% (in line) |
| 2025/Q1 | 2025-04-30 | -- | ±12.79% | +3.02% (in line) |
| 2024/Q4 | 2025-02-19 | -- | ±9.94% | -0.44% (in line) |
| 2024/Q3 | 2024-11-06 | -- | ±7.14% | +0.62% (in line) |
| 2024/Q2 | 2024-08-01 | -- | ±7.19% | +3.76% (in line) |
| 2024/Q1 | 2024-05-07 | -- | ±6.67% | -3.19% (in line) |
| 2023/Q4 | 2024-02-21 | -- | ±10.24% | -1.85% (in line) |
| 2023/Q3 | 2023-11-02 | -- | ±9.24% | -3.38% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:13:52 · For reference only, not investment advice and not tailored to your situation.